文献速递重症综合管理与镇静镇痛复苏、休克与脓毒症

IL-15改善反复脓毒症小鼠模型中衰老诱导的持续性T细胞耗竭

IL-15 Improves Aging-Induced Persistent T Cell Exhaustion in Mouse Models of Repeated Sepsis.
PubMed 文献 · Shock · 2020-01-01
一句话结论在反复脓毒症小鼠模型中,IL-15(1.5 μg皮下注射3次)可改善衰老诱导的持续性T细胞耗竭并降低脓毒症存活者的长期死亡率。

该研究在年轻(6周龄)与老龄(18-24月龄)小鼠中经腹腔注射保存的盲肠浆液4次诱导临床相关的反复脓毒症,评估脓毒症诱导T细胞耗竭的趋势及IL-15能否逆转衰老诱导的持续性T细胞耗竭。老龄脓毒症小鼠的T细胞耗竭显著重于年轻小鼠,伴初始CD4和CD8 T细胞减少(P<0.01)、T细胞程序性死亡受体1表达增加(P<0.01)及调节性T细胞群增加(P<0.01)。IL-15(1.5 μg皮下注射3次)显著改善老龄脓毒症小鼠的T细胞耗竭,显著增加自然杀伤细胞和巨噬细胞数量并增强吞噬活性(P<0.05),通过延长改善T细胞耗竭降低脓毒症存活者的长期死亡率,并改善衰老诱导的持续性T细胞耗竭。

要点

  • 老龄(18-24月龄)脓毒症小鼠的T细胞耗竭显著重于年轻(6周龄)小鼠,伴初始CD4和CD8 T细胞减少(P<0.01)。
  • 老龄脓毒症小鼠T细胞程序性死亡受体1表达增加(P<0.01)、调节性T细胞群增加(P<0.01)。
  • IL-15(1.5 μg皮下注射3次)显著改善老龄脓毒症小鼠的T细胞耗竭,并显著增加自然杀伤细胞和巨噬细胞数量、增强吞噬活性(P<0.05)。
  • IL-15通过延长改善T细胞耗竭,降低脓毒症存活者的长期死亡率并改善衰老诱导的持续性T细胞耗竭。

适用人群与场景

  • 年轻(6周龄)与老龄(18-24月龄)小鼠,经腹腔注射保存的盲肠浆液4次诱导临床相关的反复脓毒症。

处置流程与药物剂量

  • IL-15 1.5 μg皮下注射,共3次;对照为磷酸盐缓冲液皮下注射。
  • 连续测量体重,并连续50天从面颊采集外周血细胞。

研究设计与关键结果

  • 研究类型为动物实验;老龄小鼠脓毒症诱导的T细胞耗竭显著重于年轻小鼠,伴初始CD4和CD8 T细胞减少(P<0.01)、T细胞程序性死亡受体1表达增加(P<0.01)及调节性T细胞群增加(P<0.01)。
  • IL-15显著改善老龄脓毒症小鼠的T细胞耗竭,显著增加自然杀伤细胞和巨噬细胞数量并显著增强吞噬活性(P<0.05)。
  • IL-15通过延长改善T细胞耗竭,降低脓毒症存活者的长期死亡率,并改善衰老诱导的持续性T细胞耗竭。

证据类型、等级与局限

  • 证据类型:动物实验(小鼠模型)。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 原文未据此给出临床推荐。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

Aging is a grave problem in sepsis, and T cell exhaustion is the main cause of sepsis-induced immunosuppression. Sepsis- and aging-induced T cell exhaustion is related to secondary infection with a poor long-term outcome in the elderly. However, the trend, impact, and mechanism of T cell exhaustion are still unclear. Interleukin (IL)-15 improves survival rate of septic mice via its antiapoptotic effect on T cells; however, it is still unclear how IL-15 reverses prolonged T cell exhaustion in aged septic mice. The purpose of this study was to clarify the trend of sepsis-induced T cell exhaustion and whether IL-15 prevents aging-induced persistent T cell exhaustion in septic mice. Preserved cecal slurry was injected intraperitoneally into young (6-week-old) and aged mice (18-24-month-old) 4 times, to induce clinically relevant repeated sepsis. IL-15 (1.5 μg) or phosphate-buffered saline was injected subcutaneously 3 times, body weight was serially measured, and peripheral blood cells from their cheek were serially collected for 50 days. Sepsis-induced T cell exhaustion was significantly severe in aged mice than in young mice and was accompanied with decreased naive CD4 and CD8 T cells (P < 0.01) and increased expression of program death 1 on T cell (P < 0.01) and regulatory T cell population (P < 0.01). IL-15 significantly improved sepsis-induced T exhaustion, with significantly increased numbers of natural killer cells and macrophages, and significantly enhanced phagocytosis activity in aged septic mice (P < 0.05). It decreased the long-term mortality associated with sepsis survivors by improving T cell exhaustion over an extended duration and also ameliorated aging-induced persistent T cell exhaustion in septic mice.

来源:Shock,查看原文。版权归原作者所有。

参考来源

  1. Saito M, Inoue S, Yamashita K, et al. IL-15 Improves Aging-Induced Persistent T Cell Exhaustion in Mouse Models of Repeated Sepsis. Shock. 2020. PMID: 31935201. doi:10.1097/SHK.0000000000001352

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。